Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis

Circulation Research

Volumn 82, Issue 1, 1998, Pages 39-46

  Golino, Paolo ^b   Ragni, Massimo ^c   Cirillo, Plinio ^c   D'Andrea, Davide ^c   Scognamiglio, Annalisa ^c   Ravera, Amelia ^c   Buono, Chiara ^c   Ezban, Mirella ^a   Corcione, Nicola ^c   Vigorito, Francesco ^c   Condorelli, Mario ^c   Chiariello, Massimo ^c  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE

Author keywords

Active site blocked activated factor VII; Factor VII; Thrombosis; Tissue factor

Indexed keywords

ADRENALIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BLOOD FLOW VELOCITY; CAROTID ARTERY FLOW; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; ENDOTHELIUM INJURY; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0031932604     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.1.39     Document Type: Article

References (27)

1. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and clinical implications, Circulation. 1989;80:198-205.
2. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
3. Van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation. 1989;79:116-124.
4. Theroux P, Latour JG, Lager-Gauthier C, Lara JD. Fibrinopepride A and platelet factor levels in unstable angina pectoris. Circulation. 1987;75:156-162.
5. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med. 1992;326:800-806.
6. Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb, 1992;12:1111-1121.
7. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg WK, Ezekowitz MD. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 1994;74:56-63.
8. Wilcox JN, Smith KM, Schwartz S, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Prot Natl Acad Sci U S A. 1989;86:2839-2843.
9. Annex BH, Denning SM, Channon KM, Sketch MH, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes, Circulation. 1995;91:619-622.
10. Ragni M, Cirillo P, Pascucci I, Scognamiglio A, D'Andrea D, Eramo N, Ezekowitz MD, Pawashe AB, Chiariello M, Golino P. A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Ciirculation. 1996;93:1913-1920.
11. Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry. 1988;27:7785-7793.
12. Sorensen BB, Persson E, Freskgård PO, Kjalke M, Ezban M, Williams T, Rao LVM. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem. 1997;272:11863-11868.
13. Golino P, Ambrosio G, Pascucci I, Ragni M, Russolillo E, Chiariello M. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation. Thromb Haemost. 1992;67:302-305.
14. Golino P, Cappelli-Bigazzi M, Ambrosio G, Ragni M, Russolillo E, Condorelli M, Chiariello M. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation. Circ Res. 1992;71:1447-1456.
15. Golino P, Ragni M, Cirillo P, Pascucci I, Ezekowitz MD, Pawashe A, Scognamiglio A, Pace L, Guarino A, Chiariello M. Aurintricarboxylic acid reduces platelet deposition in stenosed and endothelially injured rabbit carotid arteries more effectively than other antiplatelet interventions. Thromb Haemost. 1995;74:974-980.
16. Davies MJ, Woolf N. Atherosclerosis: what is it and why does it occur? Br Heart J, 1993;69(suppl):S3-S11.
17. Harker LA, Hanson SR, Wilcox JN, Kelly AB. Antithrombotic and anti-lesion benefits without hemorragie risks by inhibiting tissue factor pathway. Haemostasis. 1996;26(suppl l):76-82.
18. Morrisey JH, Fair DS, Edgington TS. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell. 1987;50:129-135.
19. Spicer EK, Horton B, Bloern L, Bach R, Williams KR, Guha A, Kraus J, Lin TC, Nemerson Y, Konisberg WH. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A. 1987;84:5148-5152.
20. Schullek JR, Ruf W, Edgington TS. Key ligand interface residues in tissue factor contribute independently to factor VIIa binding. J Biol Chem. 1994; 269:19399-19403.
21. Ruf W, Schullek JR, Stone MJ, Edgington TS. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry. 1994;33:1565-1572.
22. Higashi S, Nishimura H, Aita K, Iwanaga S. Identification of regions of bovine factor VII essential for binding to tissue factor. J Biol Chem. 1994; 269:18891-18898.
23. Ploplis VA, Edgington TS, Fair DS. Initiation of the extrinsic pathway of coagulation: association of factor Vila with a cell line expressing tissue factor. J Biol Chem. 1987;262:9503-9508.
24. Sevinsky JR, Rao LVM, Rul W. Ligand-induced protease receptor translocaoon into caveolae mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996;133:293-304.
25. Broze GJ Jr, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 1990;29:7539-7546.
26. Lefkovits J, Topol EJ. Direct thrombin inhibitors in cardiovascular medicine. Circulation. 1994;90:1522-1536.
27. Topol EJ, Bonan R, Jewitt D, Sigwart U, Kakkar VV, Rothman M, de Bono D, Ferguson J, Willerson JT, Strony J, Ganz P, Cohen MD, Raymond R, Fox I, Maraganore J, Adelman B. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. 1993;87:1622-1629.